Starting your own business is an exciting but also demanding undertaking. We will work with you to determine which way to go: partner with an existing company or organisation, or embark on the adventure of starting your own company. Once you developed a solid business case and the decision has been made to launch your spin-off, IXA is here to assist you.
IXA offers budding entrepreneurs a full range of support options:
The Demonstrator Lab is a pre-incubator where bright ideas are transformed into innovative products and services. It is open to students and staff members of the Amsterdam universities. It provides office and laboratory space in an entrepreneurial-minded academic environment.
Amsterdam Venture Studios (AVS)
Amsterdam Venture Studios are the incubator facilities for innovative knowledge based start-ups. AVS offers workspace and dedicated support through joint incubation programs, training and mentoring, and much more.
ACE helps students, researchers, and alumni turning their ideas into successful companies, by offering the best training and support, and providing access to an extensive network of mentors, entrepreneurs and business professionals.
A new spin-off of Amsterdam UMC, location AMC, HaemoPulse, started in the first months of 2019. HaemoPulse will develop non-invasive optical technology for continuous real-time monitoring of blood hematocrit. Being able to measure hematocrit in such a manner opens a wide range of clinical applications, such as tracking of fluid balance in critically ill patients […]News
VU onderzoekt samen met LTP Business Psychologen of kunstmatige intelligentie (KI) gebruikt kan worden om de persoonlijkheid van sollicitanten te beoordelen aan de hand van gedrag en emoties die ze tonen in het gesprek. Reinout de Vries, persoonlijkheidspsycholoog en universitair hoofddocent aan de VU en hoogleraar aan de Universiteit Twente., is door De Telegraaf geïnterviewd. […]News
Rodin Therapeutics and Amsterdam Neuroscience of Amsterdam UMC announced the launch of two clinical trials; the first which has started meanwhile will assess the performance of a new PET ligand that can measure synaptic density in the living brain; the outcome of this first trial should provide insights to guide Rodin’s upcoming Phase 1b trial […]News